Sunday 18 October 2026 Export LCTX’s income statement to Excel — free account

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 53.2% from fiscal 2024. In the quarter to June 2026, revenue fell 61.3%, EPS grew 104.8%, free cash flow fell 32.4% and total debt fell 68.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.98 0.01 −1.01%

Follow LCTX

Alert me

Market cap: $250.5M
P/E: 0.0×
Fwd P/E: −17.0×
Dividend yield: —
F-score: 5/9
Altman Z: −2.91
Beneish M: −3.98
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(158.10%)	(105.57%)	(98.51%)	(60.35%)
Piotroski F-Score Full definition →		5	5	5	6
ROA Full definition →		(72.66%)	(56.27%)	(58.03%)	(32.75%)
ROIC Full definition →		0.00%	0.00%	0.00%	(186.79%)
Return on Tangible Assets Full definition →		(193.11%)	(126.17%)	(127.11%)	(67.96%)
Average Days of Receivables Full definition →		4.29	22.34	19.91	22.04
Free Cash Flow per Share Full definition →		(0.09)	(0.08)	(0.09)	(0.10)
Free Cash Flow Full definition →		(20.87)	(19.44)	(22.59)	(24.39)
Capital Expenditures Full definition →		(0.49)	(0.52)	(0.48)	(0.57)
Other line items
Cash ROIC Full definition →		(34.04%)	(19.61%)	(21.29%)	(22.04%)
Accounts Receivable Turnover Full definition →		40.66	19.04	29.01	25.02
Accounts Payable Turnover Full definition →		0.05	0.02	0.00	0.00
Inventory Turnover Full definition →		0.00	0.00	—	—
Average Days of Payables Full definition →		7,097.22	17,952.50	0.00	0.00
Days of Inventory on Hand Full definition →		0.00	0.00	—	—
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		119.40%	121.80%	127.54%	156.82%
Selling, General and Administrative Expense of Revenue Full definition →		166.50%	126.82%	126.44%	147.86%
Share Based Compensation of Revenue Full definition →		45.94%	32.65%	31.85%	38.75%
Operating CF/Net income Full definition →		0.30	0.30	0.34	0.74
Depreciation/Fixed assets Full definition →		7.16	6.03	6.21	0.33
Capex/Depreciation Full definition →		(0.03)	(0.03)	(0.03)	(0.70)
Revenue per Share Full definition →		0.05	0.06	0.06	0.05
Operating CF per Share Full definition →		(0.09)	(0.08)	(0.09)	(0.10)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.05	0.04	0.03	0.04

Show all line items

Columns are period end dates

Stockrow Weekly